Compare NNNN & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | ODC |
|---|---|---|
| Founded | 2021 | 1941 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 1994 |
| Metric | NNNN | ODC |
|---|---|---|
| Price | $31.82 | $75.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.1K | ★ 47.4K |
| Earning Date | 04-07-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 50.45 |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $485,572,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $446.57 | ★ $44.13 |
| Revenue Growth | N/A | ★ 10.97 |
| 52 Week Low | $7.58 | $45.61 |
| 52 Week High | $55.65 | $79.20 |
| Indicator | NNNN | ODC |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 56.69 |
| Support Level | $26.31 | $70.67 |
| Resistance Level | $44.06 | $79.20 |
| Average True Range (ATR) | 2.86 | 2.32 |
| MACD | 0.59 | -0.43 |
| Stochastic Oscillator | 70.78 | 63.73 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.